Market News & Trends
Mucosis Announces Positive Data for Mimopath Platform
Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal vaccines are safe and well tolerated as well as able to produce…
Novozymes Now Supplying Hyasis, a Novel Pharmaceutical-Grade HA
Novozymes Biopharma, part of Novozymes A/S, recently announced the first shipment of the company's Bacillus-derived hyaluronic acid, Hyasis, from its newly inaugurated manufacturing facility in…
5/9/2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license agreement with Novo Nordisk A/S.…
Caisson Biotech Enters Potential $100 Million Agreement
Caisson Biotech, L.L.C. recently announced it has entered into a development and license agreement with Novo Nordisk A/S. The agreement gives Novo Nordisk the exclusive…
Celsion & Focused Ultrasound to Explore ThermoDox Combined With Focused Ultrasound
Celsion Corporation and the Focused Ultrasound Foundation recently announced their support for preclinical studies designed to explore the use of ThermoDox, Celsion's Phase III, proprietary,…
Midatech & MonoSol Rx Announce Positive Results for Transbuccal Oral Insulin Film
Midatech Ltd. and MonoSol Rx LLC recently announced positive bioavailability and pharmacokinetic results from a first-in-human Phase I clinical study of their Midaform Insulin PharmFilm…
Novozymes' rAlbumin Supports Faster Time-to-Market for Neomend Adhesion Barrier Sealant
Novozymes Biopharma recently announced that its recombinant human albumin (rAlbumin), Albucult, is being used by Neomend in the company's Progel Adhesion Barrier Sealant product, which…
Prosonix Demonstrates Improved Delivery & Co-Localization of Respiratory Medicines
Prosonix recently announced the publication of a new review paper describing how its novel particle-engineering-led approach to respiratory medicines is enabling the development of "smart"…
Royalty Pharma Buys an Interest in Fumaderm for $761 Million
Royalty Pharma recently announced it had acquired an interest in the earn-out payable to the former shareholders of Fumapharm AG for $761 million in cash.…
3M DDS to Enhance Manufacturing Capabilities
3M Drug Delivery Systems recently announced the expansion of the pressurized metered dose inhaler (pMDI) fill line at its facility in Northridge, CA, significantly extending the company's…
5/1/2012
3M DDS to Enhance Manufacturing Capabilities 3M Drug Delivery Systems recently announced the expansion of the pressurized metered dose inhaler (pMDI) fill line at its facility in…
AAIPharma Services Opens New Technology Center, Will Add Jobs
AAIPharma Services Corp. officially opened a 40,000-sq-ft, state-of-the-art Technology Center on its Wilmington, NC, headquarters campus as part of a $15-million capital expansion program. The…
Harlan & Ipsen Enter Agreement to Enhance Early Stage Development Services
Harlan Laboratories Contract Research Services (CRS) and Ipsen, a global specialty-driven pharmaceutical company, recently announced they have strengthened their collaboration with a new business agreement.…
OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, recently announced positive interim analysis of data…
Strength of Aptalis Pharmaceutical Technologies Patents Confirmed by AMRIX Verdict
Aptalis Pharmatech, Inc. (previously known as Eurand, Inc.); Cephalon, Inc., a wholly owned subsidiary of Teva Pharmaceuticals Industries Ltd; and Anesta AG prevailed in their…
Ypsomed Launches New Commercial Product
Ypsomed recently announced it is expanding its mylife product range with the innovative self-injection system mylife DailyDose, which will initially be sold in six European…
4/25/2012
Alitair Announces Patent Allowance for Platform Delivery Technology Alitair Pharmaceuticals, Inc., a mid-stage pharmaceutical company with multiple respiratory product candidates in development, recently announced it…
Alitair Announces Patent Allowance for Platform Delivery Technology
Alitair Pharmaceuticals, Inc., a mid-stage pharmaceutical company with multiple respiratory product candidates in development, recently announced it has received a Notice of Allowance from the…
Baxter International's New Plant to Bring 1,500 High-Paying Jobs
Baxter International Inc. recently announced it will build a new state-of-the-art manufacturing facility in Georgia to support growth of its plasma-based treatments. These therapies include…
EMD Millipore Launches Model for In Vitro Transdermal Diffusion Studies
EMD Millipore recently introduced Strat-M membrane for screening compounds and formulations via in vitro diffusion studies. The synthetic membrane can be successfully used in place…
